section name header

Pronunciation

i-me-PEN-em/sye-la-STAT-in

Classifications

Therapeutic Classification: anti-infectives

Pharmacologic Classification: carbapenems

Indications

REMS


Action

  • Imipenem binds to the bacterial cell wall, resulting in cell death.
  • Combination with cilastatin prevents renal inactivation of imipenem, resulting in high urinary concentrations.
  • Imipenem resists the actions of many enzymes that degrade most other penicillins and penicillin-like anti-infectives.
Therapeutic effects:
  • Bactericidal action against susceptible bacteria.

Spectrum:

Pharmacokinetics

Absorption: IV administration results in complete bioavailability.

Distribution: Widely distributed to tissues.

Metabolism/Excretion: 70% excreted unchanged by the kidneys.

Half-Life: 1 hr ( in renal impairment).

Time/Action Profile

(plasma concentrations)

ROUTEONSETPEAKDURATION
IVrapidend of infusion6–8 hr





Contraind./Precautions

Contraindicated in:

Use Cautiously in:

Adv. Reactions/Side Effects

Interactions

Drug-drug:

Route/Dosage

Renal Impairment

Availability

(Generic available)

Assessment

Lab Test Considerations:

Implementation

Patient/Family Teaching

Evaluation/Desired Outcomes

US Brand Names

Primaxin